RWLK

Rewalk Robotics Limited

Healthcare Medical Devices NASDAQ

About the company

Founded in 2001, ReWalk Robotics Ltd is a pioneer in the field of medical devices, specifically focused on developing and commercializing exoskeleton systems known as ReWalk. Headquartered in Yokneam, Israel, this innovative company has made significant strides in enhancing the lives of individuals with mobility impairments. The ReWalk system represents a groundbreaking advancement in assistive technology, providing wheelchair-bound individuals with the ability to stand and walk once again. By utilizing robotic exoskeletons, ReWalk offers a transformative solution for those who have suffered from spinal cord injuries, stroke, or other conditions that have resulted in limited lower limb mobility. One of the primary offerings from ReWalk Robotics is the ReWalk Personal system. This exoskeleton is designed for everyday use, allowing users to integrate it seamlessly into their daily routines at home and in their communities. Each ReWalk Personal system is custom-fitted to the individual, ensuring optimal comfort and functionality. With the ReWalk Personal system, users can regain independence and experience the physical and psychological benefits of standing and walking upright. In addition to the ReWalk Personal system, ReWalk Robotics also offers the ReWalk Rehabilitation system. This particular exoskeleton is specifically designed for use in clinical rehabilitation environments, providing users with valuable training exercises and therapy. The ReWalk Rehabilitation system enables healthcare professionals to assist patients in relearning walking techniques and regain muscle strength and coordination. ReWalk Robotics has garnered significant recognition and has been approved by regulatory bodies in various countries, including the United States, European Union, and Israel. This validation has allowed the company to establish a strong presence in both the American and European markets, generating a substantial portion of its revenue from these regions. The United States, being one of the largest markets for medical technology, has served as a significant revenue source for ReWalk Robotics. With a large population and a robust healthcare system, the company has been able to cater to a substantial number of individuals in need of their innovative products. Additionally, ReWalk Robotics has established strategic partnerships with rehabilitation centers and hospitals in the United States, further expanding its reach and impact. Similarly, Europe has presented a fertile ground for ReWalk Robotics to extend its market presence. With countries such as Germany, the United Kingdom, France, and Italy, which boast advanced healthcare systems and a focus on innovation, the company has been able to penetrate these markets effectively. ReWalk Robotics' commitment to providing cutting-edge solutions for individuals with mobility impairments has resonated with healthcare providers and organizations throughout Europe. As the demand for advanced medical devices continues to grow, ReWalk Robotics remains at the forefront of the industry. Through ongoing research and development, the company strives to enhance its existing systems and expand its product portfolio. By harnessing the power of robotics and exoskeleton technology, ReWalk Robotics is pioneering a new era of mobility and independence for individuals with disabilities worldwide.

Website: https://www.rewalk.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1345 peers in sector

Metric RWLK Sector median Vs. industry
P/E - 20.13
EPS -0.36 USD -1.14 USD ↑ Above average
Dividend yield 0.00% 0.00%
Profit margin -2.38% 0.00% ↓ Below average
ROE -34.24% -58.89% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Rewalk Robotics Limited?
Founded in 2001, ReWalk Robotics Ltd is a pioneer in the field of medical devices, specifically focused on developing and commercializing exoskeleton systems known as ReWalk. Headquartered in Yokneam, Israel, this innovative company has made significant strides in enhancing the lives of individuals with mobility impairments. The ReWalk system represents a groundbreaking advancement in assistive technology, providing wheelchair-bound individuals with the ability to stand and walk once again. By utilizing robotic exoskeletons, ReWalk offers a transformative solution for those who have suffered from spinal cord injuries, stroke, or other conditions that have resulted in limited lower limb mobility. One of the primary offerings from ReWalk Robotics is the ReWalk Personal system. This exoskeleton is designed for everyday use, allowing users to integrate it seamlessly into their daily routines at home and in their communities. Each ReWalk Personal system is custom-fitted to the individual, ensuring optimal comfort and functionality. With the ReWalk Personal system, users can regain independence and experience the physical and psychological benefits of standing and walking upright. In addition to the ReWalk Personal system, ReWalk Robotics also offers the ReWalk Rehabilitation system. This particular exoskeleton is specifically designed for use in clinical rehabilitation environments, providing users with valuable training exercises and therapy. The ReWalk Rehabilitation system enables healthcare professionals to assist patients in relearning walking techniques and regain muscle strength and coordination. ReWalk Robotics has garnered significant recognition and has been approved by regulatory bodies in various countries, including the United States, European Union, and Israel. This validation has allowed the company to establish a strong presence in both the American and European markets, generating a substantial portion of its revenue from these regions. The United States, being one of the largest markets for medical technology, has served as a significant revenue source for ReWalk Robotics. With a large population and a robust healthcare system, the company has been able to cater to a substantial number of individuals in need of their innovative products. Additionally, ReWalk Robotics has established strategic partnerships with rehabilitation centers and hospitals in the United States, further expanding its reach and impact. Similarly, Europe has presented a fertile ground for ReWalk Robotics to extend its market presence. With countries such as Germany, the United Kingdom, France, and Italy, which boast advanced healthcare systems and a focus on innovation, the company has been able to penetrate these markets effectively. ReWalk Robotics' commitment to providing cutting-edge solutions for individuals with mobility impairments has resonated with healthcare providers and organizations throughout Europe. As the demand for advanced medical devices continues to grow, ReWalk Robotics remains at the forefront of the industry. Through ongoing research and development, the company strives to enhance its existing systems and expand its product portfolio. By harnessing the power of robotics and exoskeleton technology, ReWalk Robotics is pioneering a new era of mobility and independence for individuals with disabilities worldwide.
How big is Rewalk Robotics Limited?
The market capitalization of Rewalk Robotics Limited — the combined value of all its shares — is 62.5 M USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Rewalk Robotics Limited pay dividends?
The dividend yield of Rewalk Robotics Limited is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Rewalk Robotics Limited belong to?
Rewalk Robotics Limited operates in the Healthcare sector, industry: Medical Devices.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120